Background A significant proportion of upper gastrointestinal cancers (UGICs) remain
undetected during esophagogastroduodenoscopy (EGD). We investigated the …

Background and study aims: Upper gastrointestinal (UGI) cancer in the Western world
usually presents at an advanced stage, when opportunities for curative therapy are limited …

Abstract Background and Aims Up to 14% of upper gastrointestinal cancer (UGIC) subjects
underwent esophago-gastro-duodenoscopy (EGD) in the preceding 3 years, which did not …

OBJECTIVES: Little is known about missed rates of upper gastrointestinal cancer (UGC) in
Western populations, with most data originating from Japanese centers quoting high missed …

Background & Aims Single-center studies have estimated that 4.6% to 25.8% of gastric
cancers are missed at endoscopy. We performed a population-based study to make a more …

Objectives Esophagogastroduodenoscopy (EGD) is considered a very effective method to
identify gastric cancer (GC). However, the existence of missed lesions has been frequently …

Background Missing upper gastrointestinal cancer (UGIC) at endoscopy may prevent
curative treatment. We have developed a root cause analysis system for potentially missed …

Background and study aims: Several studies have suggested that a significant minority of
esophageal cancers are missed at endoscopy The aim of this study was to estimate the …

Simple Summary Stomach cancer may be missed during upper endoscopy. We have
examined how often this occurs and identified factors associated with missed cancers …

Background & aims Ten percent of patients with an upper gastrointestinal cancer will have
received an esophagogastroduodenoscopy (EGD) within 3 years before diagnosis, termed …